Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin (GRAY-ZONE)
Investigator-initiated, Placebo-controlled, Randomized Trial to Assess the Efficacy and Safety of Platelet Inhibition and/ or Lipid Lowering in Non-ACS-patients With Elevated High-sensitivity Troponin Values
Sponsor: Dr. med. Mahir Karakas
Terminated
insufficient recruitment due to the pandemic situation
Other terminated trials from Dr. med. Mahir Karakas
More terminations from Dr. med. Mahir Karakas
Other Acute Chest Syndrome trials with similar outcome
Listed as NCT03820466, this PHASE3 trial focuses on Acute Chest Syndrome and remains terminated or withdrawn. Sponsored by Dr. med. Mahir Karakas, it has been updated 9 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jun 2022 — Jul 2024 [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
May 2021 — Jun 2022 [monthly]
Recruiting PHASE3
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE3
▶ Show 4 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Aug 2019 — Mar 2020 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2019 — Aug 2019 [monthly]
Not Yet Recruiting PHASE3
-
Feb 2019 — Jul 2019 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Dr. med. Mahir Karakas
For direct contact, visit the study record on ClinicalTrials.gov .